IP Verse

Generics (u.k.) Limited opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Generics (u.k.) Limited

Patent Number:
EP3263106
Title:
Method For Suppressing Bitterness Of Quinoline Derivative
Applicant:
EISAI R&D MANAGEMENT CO., LTD.
Opposition Date:
Jul 25, 2024
Patent Number:
EP3542790
Title:
Compositions Comprising A Delivery Agent And Preparation Thereof
Applicant:
NOVO NORDISK A/S
Opposition Date:
Jun 13, 2024
Patent Number:
EP3352757
Title:
Administration Of Deuterated Cftr Potentiators
Applicant:
VERTEX PHARMACEUTICALS (EUROPE) LIMITED
Opposition Date:
May 16, 2024
Patent Number:
EP3488857
Title:
Compositions Of Glp-1 Peptides And Preparation Thereof
Applicant:
NOVO NORDISK A/S
Opposition Date:
Mar 7, 2024
Patent Number:
EP3870213
Title:
Stable Semaglutide Compositions And Uses Thereof
Applicant:
NOVO NORDISK A/S
Opposition Date:
Mar 7, 2024
Patent Number:
EP2508188
Title:
Pharmaceutical Formulations Containing Dapagliflozin Propylene Glycol Hydrate
Applicant:
ASTRAZENECA AB
Opposition Date:
Feb 9, 2024
Patent Number:
EP3042669
Title:
Antitumor Agent And Antitumor Effect Enhancer
Applicant:
TAIHO PHARMACEUTICAL CO., LTD.
Opposition Date:
Dec 7, 2023
Patent Number:
EP3294283
Title:
Sacubitril-Valsartan Dosage Regimen For Treating Heart Failure
Applicant:
NOVARTIS AG
Opposition Date:
Dec 7, 2023
Patent Number:
EP2981272
Title:
Microporous Zirconium Silicate And Diuretics For The Reduction Of Potassium And Treatment Of Chronic Kidney And/Or Chronic Heart Disease
Applicant:
ZS PHARMA, INC
Opposition Date:
Dec 1, 2023
Patent Number:
EP3880197
Title:
Methods Of Treatment For Cystic Fibrosis
Applicant:
VERTEX PHARMACEUTICALS INCORPORATED
Opposition Date:
Nov 21, 2023

Competitors of Generics (u.k.) Limited

NOVO NORDISK A/S

BOEHRINGER INGELHEIM INTERNATIONAL GMBH

ABBVIE INC.

Want to track Generics (u.k.) Limited?

Feel free to send us a message here and we will get back to you